FDA Approved: ISTURISA — Supplemental Application (Recordati Rare Diseases, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ISTURISA (osilodrostat) filed by Recordati Rare Diseases, Inc., reflecting an approved update to the product's l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease

Drugs mentioned

• Isturisa (osilodrostat)

Snippet

SUPPL AP for ISTURISA (OSILODROSTAT)